Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 USD | -0.30% | -5.25% | -35.12% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-35.12% | 553M | |
+11.16% | 115B | |
+12.73% | 106B | |
-4.16% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.64% | 17.56B | |
-39.36% | 17.32B | |
+7.34% | 14.03B | |
+32.94% | 12.13B |
- Stock Market
- Equities
- NWBO Stock
- News Northwest Biotherapeutics, Inc.
- Transcript : Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call